PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+8.95%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$129M
AUM Growth
+$129M
(-37%)
Cap. Flow
-$86M
Cap. Flow
% of AUM
-66.76%
Top 10 Holdings %
Top 10 Hldgs %
46.3%
Holding
97
New
25
Increased
2
Reduced
16
Closed
25
Top Buys
| 1 |
HCA Healthcare
HCA
|
$3.95M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$3.9M |
| 3 |
Hologic
HOLX
|
$3.85M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.62M |
| 5 |
United Therapeutics
UTHR
|
$3.09M |
Top Sells
| 1 |
Merck
MRK
|
$9.9M |
| 2 |
Centene
CNC
|
$7.74M |
| 3 |
AGN
Allergan plc
AGN
|
$7.17M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
$6.22M |
| 5 |
DexCom
DXCM
|
$5.87M |
Sector Composition
| 1 | Healthcare | 86.1% |
| 2 | Industrials | 5.16% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ICU Medical
ICUI
$3.15B
| $7.56M | 3.16% | 35,000 -22,500 | -39% | -$4.86M |
|
2
Globus Medical
GMED
$8.27B
| $7.5M | 3.14% | 182,500 +53,426 | +41% | +$2.2M |
|
3
LivaNova
LIVN
$3.08B
| $7.19M | 3.01% | 90,000 -64,273 | -42% | -$5.14M |
|
|
ATHN
4
DELISTED
Athenahealth, Inc.
ATHN
| $6.65M | 2.78% | 50,000 -9,800 | -16% | -$1.3M |
|
5
Dentsply Sirona
XRAY
$2.85B
| $6.09M | 2.55% | 92,500 -67,500 | -42% | -$4.44M |
|
6
Boston Scientific
BSX
$156B
| $5.7M | 2.39% | 230,000 -160,000 | -41% | -$3.97M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $5.22M | 2.18% | 130,268 +90,268 | +226% | +$3.62M |
|
|
IVC
8
DELISTED
Invacare Corporation
IVC
| $4.67M | 1.95% | 277,274 -222,726 | -45% | -$3.75M |
|
9
Abbott
ABT
$231B
| $4.57M | 1.91% | 80,000 | – | – |
|
10
Baxter International
BAX
$12.7B
| $4.53M | 1.89% | 70,000 -65,000 | -48% | -$4.2M |
|
|
11
HCA Healthcare
HCA
$94.5B
| $3.95M | 1.65% | +45,000 | New | +$3.95M |
|
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.9M | 1.63% | +43,700 | New | +$3.9M |
|
|
13
Hologic
HOLX
$14.9B
| $3.85M | 1.61% | +90,000 | New | +$3.85M |
|
14
Axogen
AXGN
$743M
| $3.4M | 1.42% | 120,000 -109,278 | -48% | -$3.09M |
|
|
VRAY
15
DELISTED
ViewRay, Inc.
VRAY
| $3.35M | 1.4% | 362,000 -245,040 | -40% | -$2.27M |
|
|
XENT
16
DELISTED
Intersect ENT, Inc
XENT
| $3.24M | 1.36% | 100,000 -100,000 | -50% | -$3.24M |
|
|
EVHC
17
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.11M | 1.3% | 90,000 -33,192 | -27% | -$1.15M |
|
|
18
United Therapeutics
UTHR
$13.8B
| $3.09M | 1.29% | +20,909 | New | +$3.09M |
|
19
Medtronic
MDT
$119B
| $3.03M | 1.27% | +37,500 | New | +$3.03M |
|
20
Insulet
PODD
$23.9B
| $2.76M | 1.15% | +40,000 | New | +$2.76M |
|
21
Medpace
MEDP
$13.4B
| $2.54M | 1.06% | +70,000 | New | +$2.54M |
|
22
Exelixis
EXEL
$10.1B
| $2.43M | 1.02% | +80,000 | New | +$2.43M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.38M | 1% | 19,900 -4,000 | -17% | -$478K |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $2.35M | 0.98% | +604,563 | New | +$2.35M |
|
|
OTIC
25
DELISTED
Otonomy, Inc.
OTIC
| $2.25M | 0.94% | +404,742 | New | +$2.25M |
|